Surge Biswas
Co-Founder & Chief Executive Officer Nabla Bio
Founder and CEO at Nabla Bio. Scientist focused on developing AI and experimental technologies to engineer biology.
Seminars
Thursday 25th June 2026
Panel Discussion: Utilizing Discovery Platforms to Hunt for the Perfect Target & Advance T-Cell Engager Efficacy in Solid & Liquid Tumors
4:30 pm
- Discussing the methodologies currently used to identify antigens in multiple myeloma and B-cell lymphoma
- Debating whether therapeutic failure in hematologic cancers stems from T-cell exhaustion or from a lack of high-density, specific antigens to target
- Identifying shared antigens vs personalized neoantigens in solid tumor populations
Thursday 25th June 2026
Exploring the De novo Design and Hypothesis-Driven exploration of Potent T-cell Engagers with JAM-2
10:30 am
- Exploring how generative design enables the rational construction of multispecifics
- Rapid generation of developable TCEs by designing in developability
- Exploration of new target space for TAAs including complex multipass membrane proteins
- Rationale design of TCEs that optimize the immune synapse
